Amazing as it sounds, a couple from Boca Raton, Florida, actually paid a California firm $155,000 in order to clone their beloved Labrador retriever, which died from cancer one year ago. The clone is a 10-week-old puppy named Lancey, and it was delivered to them earlier this week by Lou Hawthorne, chairman of BioArts International, a biotechnology company.

Edgar and Nina Otto, the couple, started thinking about cloning Sir Lancelot, their dog, five years ago. They were one of the five families to bid and win a BioArts auction for a chance to clone their family dog. Lancey is now the world’s first commercially cloned dog and the Ottos are the first of six current clients to receive their clone.

The dog’s DNA sample was sent to the Sooam Biotech Research Foundation in Seoul, South Korea, which provides cloning services to BioArts. After scientists put the DNA into an egg, Lancey came to life on November 18. What’s really interesting is that the Ottos have nine other dogs, but they say Sir Lancelot was really special.

Even if the family looks happy with their “new” dog, the Humane Society of the United States says it’s against the commercial cloning of animals, as there is a current pet overpopulation problem, which costs millions of animals their lives and millions in public tax dollars each year.

Furthermore, many say cloning an animal won’t create one identical to the one who is gone and that cloning can’t replicate an animal’s uniqueness. The Ottos, however, say that replicating Sir Lancelot’s genetics is enough for them, as they realize Lancey might not be just like their departed dog, but they’ll love him just like the first dog.